Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Digital Imaging System Offers Superior Multiple-Biomarker Tissue Analysis

By BiotechDaily International staff writers
Posted on 09 Apr 2012
Image: Tissue IA 2.0 – Automated Image Analysis for Brightfield and Fluorescence Digital Pathology (Photo courtesy of Leica Microsystems).
Image: Tissue IA 2.0 – Automated Image Analysis for Brightfield and Fluorescence Digital Pathology (Photo courtesy of Leica Microsystems).
The Tissue IA 2.0 image analysis system provides pathology researchers with superior capability for immunohistochemistry (IHC) biomarker quantification and tissue localization. The system provides a unique combination of flexibility, automation, and ease-of-use that make it an excellent tool for discovery and translational research in pathology.

Developed and released by Leica Microsystems (Leica; Wetzlar, Germany), the research-only system, Tissue IA 2.0 features fluorescence and brightfield analysis capabilities in a single platform as well as precision cell modeling. Advanced dual staining capabilities enable researchers to identify cell cohorts at the molecular level. Use one marker to identify a population of interest and then quantify expression using a second, providing greater understanding of sample slides. Algorithms are easily adjusted and optimized for different markers, tissue, and protocols, giving a flexible platform, also for drug discovery applications.

Tissue IA 2.0 provides expert tools for retrieval of quantitative, reproducible data from tissue-based IHC studies. Powerful color separation and multimarker co-localization functionality provides advanced insight and unbiased measurement of multiple antigen immunostaining in brightfield or fluorescent samples. Sophisticated cell modeling accurately detects and quantifies differential expression of staining in cellular compartments, providing detailed insight into cytoplasmic, membrane, and nuclear biomarker localization.

“Mulitplexing is of growing importance in translational research and tools to help quantify the expression and location of multiple biomarkers concurrently in tissue are a real requirement. TissueIA 2.0 delivers for the user through offering chromogenic and fluorescence quantification and co-localization, cell based histoscoring on multicompartmental IHC staining and the power to include and exclude cell populations based on biomarker expression. In conjunction with our SCN400 F and Ariol platforms, this further expands our Digital Pathology portfolio for the life science and clinical researcher and demonstrates our ongoing commitment to this area,” said Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems. With Tissue IA 2.0, Leica's Digital Pathology portfolio provides streamlined end-to-end excellence in capture, management, and analysis of digital pathology images.

With high throughput batch analysis capacity, Tissue IA 2.0 will process whole slides, regions of interest or tissue microarray cores, and automatically integrate analysis results with user’s slides. A built-in upload interface facilitating integration of algorithms from third party software solutions, gives greater flexibility to further expand analysis options. The system includes a web-accessible interface, enabling users to take their analyses wherever they go.

Leica Microsystems will be at the American Association for Cancer Research Annual Meeting 2012, March 31 to April 4, Chicago, IL. Visit booth 4103 to experience this new image analysis solution for Digital Pathology.


Related Links:
Leica Microsystems
Tissue IA 2.0



Channels

Genomics/Proteomics

view channel
Image: The photo shows a mouse pancreatic islet as seen by light microscopy. Beta cells can be recognized by the green insulin staining. Glucagon is labeled in red and the nuclei in blue (Photo courtesy of Wikimedia Commons).

Regenerative Potential Is a Trait of Mature Tissues, Not an Innate Feature of Newly Born Cells

Diabetes researchers have found that the ability of insulin-producing beta cells to replicate and respond to elevated glucose concentrations is absent in very young animals and does not appear until after weaning.... Read more

Drug Discovery

view channel
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).

Human Heart-on-a-Chip Cultures May Replace Animal Models for Drug Development and Safety Screening

Human heart cells growing in an easily monitored silicon chip culture system may one day replace animal-based model systems for drug development and safety screening. Drug discovery and development... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.